Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. PENNY STOCK TWEETS Message Board

$AMBS at 5 cents? Closed down 28%? You guys do n

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 12947
Posted On: 11/07/2012 6:24:45 PM
Avatar
Posted By: AAAAMHIM


$AMBS at 5 cents? Closed down 28%? You guys do not under stand how big their trials with MANF are. Big pharma could come calling anytime soon. Micheal J fox foundation has sent funding and continues to assist in funding. This could be a $1, 12, $45 stock if they get through phase 3. Shorts are playing a very dangerous game here. it is AT BOTTOM here watch how ferocious the bounce is going to be it almost hit 9 cents yesterday, this pullback was HEALTHY, newer STRONGER hands coming in, and BIG MONEY hits on the ask LOOK at the trades today. Look at what the CO FOUNDER of Amgen AMGN recently stated. This no ordinary penny stock here, only 1 00 million o/s and 250 A/S See you at 15 cents





Dr. Rubinfeld co founder of Amgen said "I believe in MANF, I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen"

http://www.sbwire.com/press-releases/amarantu...178166.htm

How about Micheal J Fox

"The Michael J. Fox Foundation for Parkinson's Research deploys financial and intellectual resources at every stage of drug development to attract and expand investment in Parkinson's disease by pharmaceutical companies and follow-on funders. We share the risk of investment in promising drug targets, funding work that builds the case to advance them toward the clinic. Our on-staff PhDs and business-trained project managers collaborate closely with both industry and academic research teams to generate and support the most promising ideas that will speed potential treatments toward pharmacy shelves. Today we can say with confidence that the model we have built is accelerating progress. "






(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us